Gloria Melanie

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gloria Melanie's trades of Immunovant Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-08
S Sale
18,355 +25.7%
224.00
US$4,593,498 		18,355 +25.7% 224.00 US$4,593,498
2026-07-10 2026-07-08
S Sale
30,321 +39.4%
94.28
US$1,464,234 		30,321 +39.4% 94.28 US$1,464,234
2026-06-26 2026-06-26
S Sale
82,058 +9.8%
301.51
US$634,402 		82,058 +9.8% 301.51 US$634,402
2026-06-26 2026-06-26
S Sale
14,748 -6.1%
38.18
US$563,079 		14,748 -6.1% 38.18 US$563,079
2026-06-26 2026-06-26
PrS Proposed sale
17,714
38.31
US$678,552 		17,714 38.31 US$678,552
2026-05-22 2026-05-20
S Sale
1,698 -0.7%
32.95
US$55,949 		1,698 -0.7% 32.95 US$55,949
2026-05-22 2026-05-20
S Sale
1,168 -0.5%
32.15
US$37,551 		1,168 -0.5% 32.15 US$37,551
2026-05-22 2026-05-20
S Sale
249 -0.1%
30.41
US$7,572 		249 -0.1% 30.41 US$7,572
2026-04-10 2026-04-08
S Sale
8,722 -3.4%
24.83
US$216,567 		8,722 -3.4% 24.83 US$216,567
2026-04-10 2026-04-08
S Sale
8,722 -3.4%
24.83
US$216,567 		8,722 -3.4% 24.83 US$216,567
2026-02-27 2026-02-25
S Sale
942 -0.6%
28.90
US$27,224 		942 -0.6% 28.90 US$27,224
2026-02-27 2026-02-25
S Sale
859 -0.5%
28.16
US$24,189 		859 -0.5% 28.16 US$24,189
2026-02-27 2026-02-25
S Sale
1,437 -0.8%
26.98
US$38,770 		1,437 -0.8% 26.98 US$38,770
2025-11-21 2025-11-20
S Sale
2,375 -1.4%
23.97
US$56,929 		2,375 -1.4% 23.97 US$56,929
2025-11-21 2025-11-20
S Sale
10,251 -5.5%
23.54
US$241,309 		10,251 -5.5% 23.54 US$241,309